LINCOLN Stock Overview
Lincoln Pharmaceuticals Limited engages in manufacturing and trading of pharmaceutical products in India and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Rewards
Risk Analysis
No risks detected for LINCOLN from our risk checks.
Lincoln Pharmaceuticals Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹580.80 |
| 52 Week High | ₹755.15 |
| 52 Week Low | ₹365.25 |
| Beta | 0.68 |
| 1 Month Change | 0.62% |
| 3 Month Change | -13.95% |
| 1 Year Change | 43.30% |
| 3 Year Change | 137.21% |
| 5 Year Change | 209.68% |
| Change since IPO | 165.63% |
Recent News & Updates
Recent updates
Lincoln Pharmaceuticals Limited's (NSE:LINCOLN) Business And Shares Still Trailing The Market
Mar 14
Does Lincoln Pharmaceuticals (NSE:LINCOLN) Deserve A Spot On Your Watchlist?
Nov 04Lincoln Pharmaceuticals' (NSE:LINCOLN) Dividend Will Be ₹1.50
Sep 14Lincoln Pharmaceuticals (NSE:LINCOLN) Is Paying Out A Dividend Of ₹1.50
Aug 31Lincoln Pharmaceuticals' (NSE:LINCOLN) Dividend Will Be ₹1.50
Sep 12Lincoln Pharmaceuticals (NSE:LINCOLN) Is Due To Pay A Dividend Of ₹1.50
Aug 29If You Like EPS Growth Then Check Out Lincoln Pharmaceuticals (NSE:LINCOLN) Before It's Too Late
Feb 14Should You Be Adding Lincoln Pharmaceuticals (NSE:LINCOLN) To Your Watchlist Today?
Aug 16Here's Why I Think Lincoln Pharmaceuticals (NSE:LINCOLN) Is An Interesting Stock
May 06Is Lincoln Pharmaceuticals Limited (NSE:LINCOLN) A Smart Choice For Dividend Investors?
Apr 03Does Lincoln Pharmaceuticals (NSE:LINCOLN) Have A Healthy Balance Sheet?
Mar 15Could The Market Be Wrong About Lincoln Pharmaceuticals Limited (NSE:LINCOLN) Given Its Attractive Financial Prospects?
Feb 28Insider Buying: The Lincoln Pharmaceuticals Limited (NSE:LINCOLN) Whole Time Director Just Bought 15% More Shares
Feb 12Does Lincoln Pharmaceuticals (NSE:LINCOLN) Deserve A Spot On Your Watchlist?
Feb 01
Lincoln Pharmaceuticals (NSE:LINCOLN) Shareholders Booked A 27% Gain In The Last Five Years
Jan 19Trade Alert: The Whole Time Director Of Lincoln Pharmaceuticals Limited (NSE:LINCOLN), Munjal Patel, Has Just Spent ₹20m Buying 9.2% More Shares
Jan 06Why Lincoln Pharmaceuticals Limited (NSE:LINCOLN) Is A Dividend Rockstar
Dec 27Lincoln Pharmaceuticals's (NSE:LINCOLN) Earnings Are Growing But Is There More To The Story?
Dec 14Have Insiders Been Buying Lincoln Pharmaceuticals Limited (NSE:LINCOLN) Shares This Year?
Dec 01Declining Stock and Solid Fundamentals: Is The Market Wrong About Lincoln Pharmaceuticals Limited (NSE:LINCOLN)?
Nov 18Is Lincoln Pharmaceuticals (NSE:LINCOLN) A Risky Investment?
Nov 05Is Now The Time To Put Lincoln Pharmaceuticals (NSE:LINCOLN) On Your Watchlist?
Oct 23Lincoln Pharmaceuticals (NSE:LINCOLN) Shareholders Booked A 74% Gain In The Last Year
Oct 05Lincoln Pharmaceuticals Limited (NSE:LINCOLN) Vies For A Place In Your Dividend Portfolio: Here's Why
Sep 18Trade Alert: The MD & Whole Time Director Of Lincoln Pharmaceuticals Limited (NSE:LINCOLN), Mahendrabhai Patel, Has Just Spent ₹2.4m Buying 2.0% More Shares
Aug 31Earnings Working Against Lincoln Pharmaceuticals Limited's (NSE:LINCOLN) Share Price
Aug 21Shareholder Returns
| LINCOLN | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -3.8% | -2.8% | -1.5% |
| 1Y | 43.3% | 54.9% | 45.0% |
Return vs Industry: LINCOLN underperformed the Indian Pharmaceuticals industry which returned 54.9% over the past year.
Return vs Market: LINCOLN underperformed the Indian Market which returned 45% over the past year.
Price Volatility
| LINCOLN volatility | |
|---|---|
| LINCOLN Average Weekly Movement | 5.6% |
| Pharmaceuticals Industry Average Movement | 5.9% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: LINCOLN's share price has been volatile over the past 3 months.
Volatility Over Time: LINCOLN's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1979 | 1,645 | Mahendrabhai Patel | www.lincolnpharma.com |
Lincoln Pharmaceuticals Limited engages in manufacturing and trading of pharmaceutical products in India and internationally. The company provides products in the areas of cough and cold, anti-allergic, and anti-asthmatics; sterile ophthalmic eye drops and ointment; anti-malarial; vitamins, minerals, and antioxidants; anti-bacterial, anti-viral, and anti-fungal vitamins; analgesic and anti-pyretic; anti-psychotic, anti-convulsant, anti-depressant, and anti-diabetic; cardiac anti-hypertensives, and diuretic; and anti-diarrheal, anti-spasmodic, and laxative, as well as dermatologist preparations, gynecological products, gastrointestinal rang, otology products, and phosphodiesterase type 5 inhibitor and general anesthetics. It also offers branded generics.
Lincoln Pharmaceuticals Limited Fundamentals Summary
| LINCOLN fundamental statistics | |
|---|---|
| Market cap | ₹11.63b |
| Earnings (TTM) | ₹872.70m |
| Revenue (TTM) | ₹5.51b |
13.3x
P/E Ratio2.1x
P/S RatioIs LINCOLN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| LINCOLN income statement (TTM) | |
|---|---|
| Revenue | ₹5.51b |
| Cost of Revenue | ₹2.58b |
| Gross Profit | ₹2.93b |
| Other Expenses | ₹2.06b |
| Earnings | ₹872.70m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 30, 2024
| Earnings per share (EPS) | 43.57 |
| Gross Margin | 53.21% |
| Net Profit Margin | 15.85% |
| Debt/Equity Ratio | 0.2% |
How did LINCOLN perform over the long term?
See historical performance and comparison